Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

Phase 2

Completed

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT00482417
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

Efficacy and Safety Study of MK0359 in Patients with Arthritis

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2002-12
• Primary Completion: 2003-05
• Study Completion: 2003-05
• Study First Submitted: 2007-06-01
• Study First Submitted QC: 2007-06-01
• Study First Posted: 2007-06-05
• Status Verified: 2015-11
• Last Update Submitted: 2015-11-19
• Last Update Posted: 2015-11-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

• You are 18-65 years of age and have Rheumatoid Arthritis
• You must be able to read and understand patient questionnaires

Read More

Exclusion Criteria

• You have had certain types of surgery, certain types of cancer or history of Tuberculosis (TB) or HIV.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL